4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-103037
Chief Medical Officer acquired 47,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Kerr Douglas · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-03 | Grant or award : show line 1 in the form | +47,500 | 47,500 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-09-03 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +150,300 | 150,300 | D |
Loading xslF345X05/ownership.xml…